Ayurvedic treatment for mild and moderate depression

A DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED TRIAL ON SIDDHARTHAKA YOGA IN THE MANAGEMENT OF MILD & MODERATE DEPRESSION

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020868

Enrollment

140

Registered

2019-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

Intervention1: Siddharthaka yoga: Capsule form of Siddharthaka yoga weighing about 500 mgs 2 capsules each will be administred after food 3 times per day for 2 months Control Intervention1: Placebo: I

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as suffering from mild and moderate depression

Exclusion criteria

Exclusion criteria: 1.Patients suffering from severe depression 2.Patients having suicidal ideation. 3.Patients associated with major organic pathologies.

Design outcomes

Primary

Measure	Time frame
Hamilton depression rating scale will be assessed in every 1 month during the treatment and after one month of completion of treatment.Timepoint: 8 weeks	—

Secondary

Measure	Time frame
Assessement beck depression inventoryTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactDr Vaishali Deshapande

Parul institute of ayurveda and Research Waghodia Vadodara

drvaishalid@gmail.com9096082950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026